Literature DB >> 10645694

Health awareness and treatment compliance of high blood pressure among women in a peri-urban colony of Chandigarh, India.

K Thakur1, P Malhotra, I Walia, R Kumar.   

Abstract

Health awareness is a central issue in the control of hypertension. In a cross-sectional survey among 1727 women of > 30 years, 2 blood pressure recordings were done in 1686 cases. The prevalence of hypertension was found to be 13.1% (221 out of 1686 cases). A random sub sample of 72 hypertensive women above 30 years of age from a peri-urban colony of Chandigarh was selected to find out health awareness and treatment compliance of hypertension. Sixty-three (87.5%) of the selected women were aware of their high blood pressure. However, only 12 women (16.7%) who were on treatment had achieved control of blood pressure (< 140/90 mm Hg). Main reasons for discontinuing the treatment were ignorance about the need of regular treatment (33.3%), high cost of medicines (19.44%) and non-availability of a family member who can go with the patient to hospital (9.72%). Twenty-six (36.1%) hypertensive women did not know the importance of weight reduction for controlling high blood pressure. Twenty-three (31.9%) hypertensive women were currently smoking. A comprehensive health education approach involving health care professionals, patients and general population should be launched to improve the care of hypertensives in the community.

Entities:  

Mesh:

Year:  1999        PMID: 10645694

Source DB:  PubMed          Journal:  J Indian Med Assoc        ISSN: 0019-5847


  2 in total

1.  Effectiveness of telemedicine: videoconferencing for low-income elderly with hypertension.

Authors:  Hanna Choi; Jeongeun Kim
Journal:  Telemed J E Health       Date:  2014-12       Impact factor: 3.536

2.  Treatment Compliance among Patients with Hypertension and Type 2 Diabetes Mellitus in a Coastal Population of Southern India.

Authors:  Chythra R Rao; Veena G Kamath; Avinash Shetty; Asha Kamath
Journal:  Int J Prev Med       Date:  2014-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.